Analytical Data
-
基因名
FLK-1/VEGFR-2
-
简介
VEGFR-2 protein is an important tyrosine protein kinase receptor. As a cell surface receptor for VEGFA, VEGFC and VEGFD, it plays an important role in the regulation of angiogenesis, vascular development, permeability and embryonic hematopoiesis. It actively promotes endothelial cell proliferation, survival, migration, differentiation, and actin cytoskeletal reorganization. VEGFR-2 Protein, Mouse (743a.a, HEK293, mFc) is the recombinant mouse-derived VEGFR-2 protein, expressed by HEK293, with C-mFc labeled tag.
- Application
-
别名
Vascular endothelial growth factor receptor 2; VEGFR-2; FLK-1; NYK; CD309
-
种属
Mouse
-
表达系统
HEK293
-
标签
C-mFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P35918
-
表达区间
A20-E762
-
蛋白长度
Extracellular Domain
-
分子量
120-135 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLK-1, also known as VEGFR-2 (Vascular Endothelial Growth Factor Receptor 2), is a key receptor in the vascular endothelial growth factor signaling pathway, primarily involved in angiogenesis and vascular permeability. The study of FLK-1/VEGFR-2 recombinant protein has gained significant attention due to its crucial role in both normal physiological processes and pathological conditions, such as cancer, where tumor growth and metastasis often rely on the formation of new blood vessels. Understanding the structure and function of FLK-1/VEGFR-2 can provide insights into its mechanism of action and its interaction with various ligands, such as VEGF-A. Moreover, the development of FLK-1/VEGFR-2 antagonists or inhibitors holds therapeutic potential, particularly in oncology, as targeting this pathway may prevent tumor angiogenesis and improve clinical outcomes. Additionally, research into FLK-1/VEGFR-2 can enhance our understanding of cardiovascular diseases, as dysregulation of this receptor can lead to various vascular disorders. Overall, the investigation of FLK-1/VEGFR-2 recombinant protein is pivotal in developing strategies for disease management and targeted therapies, making it a significant focus in biomedical research.
